| |
|
|
| |
|
|
 Issue
017 |
|
Where
technology meets versatility
Alfa Wasserman
Since it was established in 1948, Alfa Wassermann
SpA has been deeply rooted in the Italian pharmaceutical
market through the research, production and marketing
of prescription and over-the-counter drugs. more... |
| |
|
|
| |
Business
expansion in Brazil
Nycomed
Nycomed is to strengthen its focus on the Brazilian
market and plans to double business volume in the
country over the next five years. more... |
|
| |
|
|
| |
The
outsourcing code
Rechon Life Science
Passion and professionalism create the right conditions
for successful outsourcing, explains Anders Ulfhielm,
executive vice-president, business development for
Rechon Life Science. more... |
|
| |
|
|
| |
Made
in Poland
Medicofarma
Medicofarma is a privately owned Polish pharmaceutical
and nutraceutical contract manufacturer. Its core
business is contract packaging, manufacturing and
developing. more...
|
|
| |
|
|
| |
A
tradition of competence
Lomapharm
Lomapharm specialises in the production of tablets
and liquid pharmaceuticals and high-quality dietary
supplements. Founded in 1878, this family-run company
is one of three affiliated companies within the
Lohmann Group, located near Hamelin, Germany. more... |
|
|
 Issue
016 |
Raw
Materials |
Blue
sky innovation...continued
Provepharm SAS
Thanks to its significantly improved safety profile,
ProveBlue methylene blue opens the way to widespread
clinical testing of its pharmacological properties
in a number of life-threatening diseases. more...
|
| |
High-quality,
low-cost cooperation
AqVida
Assisting the development, registration and marketing
of generic drugs in Europe is the main focus for
pharmaceutical firm AqVida. The company’s
managing director Wolfgang Heinze talked to World
Pharmaceutical Frontiers about the added value offered
to international manufacturers and local clients
in the EU. more...
|
| |
Environment
for innovation in excipients
Kerry Group
Combined resources help Sheffield partner with customers
to deliver coating and tableting solutions that
offer greater manufacturing performance, improved
reliability and cost savings. more...
|
| |
Be
happy, use TAPI
TAPI
With ever-increasing and stiffer regulatory barriers
for high-quality active pharmaceutical ingredients
(API), one of the largest API producers in the world
offers peace of mind for purchasing. Years of specialisation
combined with a global presence and high production
standards ensure superior quality while keeping
prices affordable. more...
|
| |
| |
Drug
Discovery & Development |
Determining
siRNA selection
Life Technologies
What is important when selecting an siRNA library?
Design and performance are just a starting point
for the use of this technology. more...
|
| |
|
|
| |
|
Regulatory
standards achieved offshore
Medicilon/MPI Preclinical
Research Shanghai
As the US celebrates the 30th anniversary of Good
Laboratory Practices (GLP), William Harrison, president
and COO of MPI Research, discusses the integration
of these standards in Shanghai, China. more...
|
| |
|
|
| |
|
MicroRNAs
in disease discovery
Thermo Fisher Scientific
Further understanding of gene expression could lead
to faster diagnosis and lower incidence of disease.
One company’s microRNA mimicking system is
helping to expand the market for genetic regulation.
more...
|
| |
|
|
| |
|
The
safety-efficacy challenge
CRO
With a huge amount of pharma’s money wasted
on failed products, how can biomarkers help reduce
costs and ensure the safety and effectiveness of
drugs before they reach the market? more...
|
| |
|
|
| |
Clinical
Trials |
Expect
more from your CRO
INC Research
To get ahead in the contract research market, companies
need to forge strong, often international customer
relationships. Client feedback and process-driven
research offer numerous benefits. more...
|
| |
|
|
| |
|
Cost
effectiveness in clinical trials
HCR
It can cost $1 billion to bring a new drug to market.
Economic, scientific and political pressures to
reduce healthcare costs, generic competition and
short patent protection times are a challenging
scenario for pharma today. more...
|
| |
|
|
| |
|
One
biomarker at a time
Quest Diagnostics
New technologies are driving the integration of
the next-generation of biomarkers into clinical
trials. Quest Diagnostics provides differentiated
biomarker assays, accelerating clinical research
programmes through its assay development and laboratory
management services. more...
|
| |
|
|
| |
|
Powerful
new connections
Quotient
Dr David Griffiths provides an insight into a fast-growing
company that has brought together well-known specialists
in radiochemistry, metabolism, bioanalysis and biomarkers,
early and specialist clinical trials, and microbiology,
to provide a unique portfolio of solutions relevant
to today’s product development. more...
|
| |
|
|
| |
|
Global
contract manufacturing
Nycomed
To tackle the emerging pharmaceutical markets set
to experience high growth in demand, manufacturing
competence that meets quality standards is required.
This is particularly important in the area of sterile
products and packaging. more...
|
